MICHAEL DOSIK
Medical Practice at Conscience Cir, Strongs Neck, NY
License number
Alaska MEDS6207
Issued Date
Oct 30, 2007
Expiration Date
Dec 31, 2016
Category
Medical
Address
Address
22 Conscience Cir, Strongs Neck, NY 11733
Organization information
See more information about MICHAEL DOSIK at bizstanding.comMichael Dosik MD,FACP
235 N Belle Mead Ave, East Setauket, NY 11733
Industry:
Internist
Phone:
(631) 751-3000 (Phone)
Michael Henry Dosik
Michael Dosik MD
22 Conscience Cir, Strongs Neck, NY 11733
Industry:
Medical Doctor's Office
Medical Doctor, Owner:
Michael Dosik (Medical Doctor, Owner)
Professional information
Elf3 Gene Compositions And Methods
US Patent:
2010031, Dec 16, 2010
Filed:
May 17, 2010
Appl. No.:
12/800539
Inventors:
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5′ untranslated region, and a novel Alu, Alu. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
Elf3 Gene Compositions And Methods
US Patent:
7718783, May 18, 2010
Filed:
Nov 21, 2003
Appl. No.:
10/535378
Inventors:
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
International Classification:
C07H 21/02, C12Q 1/68
US Classification:
536 231, 435 6
Abstract:
ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5′ untranslated region, and a novel Alu, Alu. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
Herv Group Ii Viruses In Lymphoma And Cancer
US Patent:
2008026, Oct 23, 2008
Filed:
Sep 10, 2007
Appl. No.:
11/852369
Inventors:
David Markovitz - Ann Arbor MI, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, G01N 33/574, C12Q 1/02
US Classification:
435 6, 435 723, 435 29
Abstract:
The present invention relates to compositions and methods for cancer diagnosis and therapy, including but not limited to, cancer markers. In particular, the present invention relates to HERV-K(HML-2) target titers as diagnostic markers, and HERV-K(HML-2) therapeutic targets for HIV-related cancers, and other cancers.